about
Targeting B cells in atherosclerosis: closing the gap from bench to bedsideThe CXCL10/CXCR3 Axis and Cardiac Inflammation: Implications for Immunotherapy to Treat Infectious and Noninfectious Diseases of the HeartInhibition of microRNA-92a prevents endothelial dysfunction and atherosclerosis in miceCirculating procoagulant microparticles and soluble GPV in myocardial infarction treated by primary percutaneous transluminal coronary angioplasty. A possible role for GPIIb-IIIa antagonistsLactadherin promotes VEGF-dependent neovascularizationAseptic meningoencephalitis after iopamidol myelographyType II secretory phospholipase A2 and prognosis in patients with stable coronary heart disease: mendelian randomization studyFrench Intensive Care Society, International congress - Réanimation 2016Magnetic resonance molecular imaging of thrombosis in an arachidonic acid mouse model using an activated platelet targeted probe.Interleukin-18/interleukin-18 binding protein signaling modulates ischemia-induced neovascularization in mice hindlimb.[Etiopathogenesis of arrhythmogenic right ventricular dysplasia]Impairment in postischemic neovascularization in mice lacking the CXC chemokine receptor 3.Deficient CD40-TRAF6 signaling in leukocytes prevents atherosclerosis by skewing the immune response toward an antiinflammatory profileB lymphocytes trigger monocyte mobilization and impair heart function after acute myocardial infarction.The Pathogenic Transforming Growth Factor-β Overdrive Hypothesis in Aortic Aneurysms and Dissections: A Mirage?Type-2 innate lymphoid cells control the development of atherosclerosis in miceSecreted IgM deficiency leads to increased BCR signaling that results in abnormal splenic B cell development.Angiotensin II synergizes with BAFF to promote atheroprotective regulatory B cells.The relationship of hydroxyeicosatetraenoic acids and F2-isoprostanes to plaque instability in human carotid atherosclerosisMARK4 regulates NLRP3 positioning and inflammasome activation through a microtubule-dependent mechanismApoptosis in the vasculature: mechanisms and functional importance.Protective role of uncoupling protein 2 in atherosclerosis.Bone marrow transplantation reveals the in vivo expression of the mitochondrial uncoupling protein 2 in immune and nonimmune cells during inflammation.Deletion of chromosome 9p21 noncoding cardiovascular risk interval in mice alters Smad2 signaling and promotes vascular aneurysm.B cell depletion reduces the development of atherosclerosis in mice.Interleukin-10: an anti-atherogenic cytokine?Lipoprotein-associated and secreted phospholipases A₂ in cardiovascular disease: roles as biological effectors and biomarkers.Anti-inflammatory mechanisms in the vascular wall.Novel genetic approach to investigate the role of plasma secretory phospholipase A2 (sPLA2)-V isoenzyme in coronary heart disease: modified Mendelian randomization analysis using PLA2G5 expression levelsCirculating secretory phospholipase A2 activity predicts recurrent events in patients with severe acute coronary syndromes.Cytokines in atherosclerosis: pathogenic and regulatory pathways.Association of residual plasma viremia and intima-media thickness in antiretroviral-treated patients with controlled human immunodeficiency virus infectionChemokine receptor CCR1 disruption in bone marrow cells enhances atherosclerotic lesion development and inflammation in miceDefective leptin/leptin receptor signaling improves regulatory T cell immune response and protects mice from atherosclerosis.The role of transforming growth factor beta in atherosclerosis: novel insights and future perspectives.Hematopoietic IKBKE limits the chronicity of inflammasome priming and metaflammation.Apoptosis, a major determinant of atherothrombosis.Relationship of IgG and IgM autoantibodies and immune complexes to oxidized LDL with markers of oxidation and inflammation and cardiovascular events: results from the EPIC-Norfolk Study.Systemic chemokine levels, coronary heart disease, and ischemic stroke events: the PRIME study.Increased plasma concentrations of interleukin-18 in acute coronary syndromes.
P50
Q26828369-7B6A771A-E73E-4F17-8B89-0CA7046F5CC8Q28079006-0FC6A62E-8EC5-4377-999A-94F897044EE1Q28115933-3952BFC5-C386-486A-97D8-28C5D56A6940Q28169115-87D14EB4-4494-4548-B4A7-ABAE939C3962Q28245534-98EC384F-7967-4557-B99D-60CC47E0B06AQ28322805-4EEB1898-7E7E-4FCC-8BD1-A8E8F0ABD8EEQ28479244-BB11DE79-243D-49C0-9FFE-DA098D11695FQ28550357-5D756FAA-2C95-4CA7-B038-892A23F693DEQ30494337-1B7FF7CF-D236-43A1-93C9-BF7E58EC256FQ30846013-B2B22945-2CA3-4464-94BC-6857E8AF7B46Q33148529-9F7FDA8A-BD7C-4C29-B8D3-EE2879510856Q33212030-8ADE359B-2B05-4467-9C9C-A4D830B5C318Q33656103-11493F4A-1BFB-441C-8481-D587CD4000A0Q33704093-006F4B49-7D6D-44EF-8EF9-0C065BE10302Q33736775-9BCBFBE7-6CCD-4F29-A60F-48F3F283A9BBQ33786641-BA4BD185-FB67-475E-8CCB-03FEB07B815FQ33799269-54499DE9-B009-4053-B64F-345AF2584033Q33829848-E74CED01-2132-4955-B11A-F9C564EB2127Q33835675-0B3C4C25-680D-4145-8FE4-7D64696A60C8Q33861382-81DD5AD8-E3A4-4D9B-9091-1D4FC4983262Q33959479-D4A43F47-CA46-4E01-B1CE-49A49CD4BFF8Q33963991-365DC8A3-C6E3-42B8-B413-367A2D224B82Q33967659-7409C50E-D229-43E3-85AD-8F34FCCE0ACBQ34041869-2463CB7B-0CDA-4271-9E7E-BF44B6BA2EFFQ34044387-DB7DD168-8954-4DEB-90C1-DD3A770E6B2AQ34135638-19F5921D-A41D-4334-87C3-60888356E789Q34151396-333026EE-A142-45DA-BCD3-33F06FBF44BCQ34249006-8E1AF396-80DF-497E-9567-9152D7D04770Q34418471-F6DEB4D0-3F21-4A00-8B91-AFAD3788B5D4Q34455926-4FFCABA8-4CFB-499A-9209-F4DAC4D01BDFQ34511711-EEF3145A-44BE-4577-AF56-3A3606E754DCQ34557631-814F6167-9530-403B-BB4F-C261865C08CEQ34572318-7443E109-6BD1-4928-A855-83AF2E59A797Q34661745-2535F4EA-8CC0-4DD4-9BF2-4A0616A0EF42Q34916098-353FAEDA-2D43-4419-82D2-3728D756605DQ34985696-947B6F76-DCE7-4D6F-BD8B-EAA238B5B42CQ35179894-47B7B028-4538-4FCA-97CA-4D84A80B5717Q35212898-BD77382C-0987-4520-AB00-6F238E2A70AAQ35215601-DFD18081-A022-42EE-8BFF-B754CC13BA1BQ35580575-3F46E49B-DE62-402D-A320-40DB4618C1CB
P50
description
hulumtues
@sq
researcher
@en
ricercatore
@it
wetenschapper
@nl
հետազոտող
@hy
name
Ziad Mallat
@ast
Ziad Mallat
@en
Ziad Mallat
@es
Ziad Mallat
@nl
Ziad Mallat
@sl
type
label
Ziad Mallat
@ast
Ziad Mallat
@en
Ziad Mallat
@es
Ziad Mallat
@nl
Ziad Mallat
@sl
prefLabel
Ziad Mallat
@ast
Ziad Mallat
@en
Ziad Mallat
@es
Ziad Mallat
@nl
Ziad Mallat
@sl
P108
P214
P106
P108
P1153
7005561245
P21
P214
P31
P496
0000-0003-0443-7878
P569
2000-01-01T00:00:00Z
P735
P7859
viaf-173698067